Table 1.
Sociodemographic and clinical characteristics of hypertensive patients
| Variable | Overall (n=588) | Male (n=252) | Female (n=336) | P* |
|---|---|---|---|---|
| Age, years (%) | 0.692 | |||
| 18-27 | 1.4 | 2.4 | 0.6 | |
| 28-37 | 3.4 | 4.0 | 3.0 | |
| 38-47 | 8.3 | 8.7 | 8.0 | |
| 48-57 | 18.0 | 16.3 | 19.3 | |
| 58-67 | 31.0 | 30.6 | 31.2 | |
| 68-77 | 23.3 | 23.8 | 22.9 | |
| 78-87 | 10.2 | 9.9 | 10.4 | |
| 88 and above | 4.4 | 4.4 | 4.5 | |
| Nationality (%) | 0.019 | |||
| Emirati | 79.6 | 75.4 | 82.7 | |
| Expatriate | 20.4 | 24.6 | 17.3 | |
| Number of comorbidities (%) | 0.413 | |||
| No comorbidity | 23.6 | 22.6 | 24.4 | |
| One comorbidity | 37.5 | 40.5 | 35.1 | |
| Two comorbidity | 38.9 | 36.9 | 40.5 | |
| Type of comorbidities (%) | 0.081 | |||
| Diabetes mellitus | 8.2 | 7.1 | 8.9 | |
| Hyperlipidemia | 23.2 | 24.6 | 22.0 | |
| Ischemic heart disease | 6.0 | 8.7 | 4.2 | |
| Diabetes mellitus + hyperlipidemia | 32.7 | 29.0 | 35.4 | |
| Diabetes mellitus + ischemic heart disease | 6.3 | 7.9 | 5.1 | |
| Concomitant medications (%) | ||||
| Antidiabetic | 6.2 | 5.2 | 6.8 | 0.253 |
| Antihyperlipidemic | 12.8 | 11.5 | 13.7 | 0.255 |
| Antiplatelet | 3.0 | 4.4 | 2.1 | 0.090 |
| Antidiabetic + antihyperlipidemic | 16.6 | 12.7 | 19.6 | 0.016 |
| Antidiabetic + antiplatelet | 2.7 | 2.8 | 2.7 | 0.568 |
| Antihyperlipidemic + antiplatelet | 15 | 19.4 | 11.6 | 0.006 |
| Antidiabetic + antihyperlipidemic + antiplatelet | 21.6 | 23.4 | 20.2 | 0.205 |
| Other medications | 22.1 | 24.4 | 19.7 | 0.256 |
*Chi-square test